Stocktoria

Fuse Medical, Inc. FZMD

Fuse Medical, Inc. (FZMD) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2022 revenue was $18.6M at a 16.6% net margin.

4/9
Piotroski F — financial health
-0.25
Altman Z″ — distress risk · distress
Dividend payout · no dividend
$0.02 as of 2026-06-01 · -71.4% 1y
$0.02$0.1052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Beneish M-score: -1.6 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

P / E0.5×
Net margin16.6%
Revenue trend · last 10y · up

How it ranks in Wholesale Trade · percentile among 107 companies

Piotroski Fstronger than 32%
Net marginstronger than 94%
Revenue growthstronger than 21%

Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets0.07
Retained earnings / assets-0.127
EBIT / assets-0.041
Equity / liabilities-0.015

Sector peers · similar-size Wholesale Trade companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
FZMDFuse Medical, Inc.4/9-0.250.5-8.7%
ACHACCENDRA HEALTH INC/VA/3/9-2.59+3.1%
HSICHENRY SCHEIN INC4/92.7124.3+4%
MCKMCKESSON CORP6/90.5818.8+12.4%
CAHCARDINAL HEALTH INC6/9-0.0335.7-1.9%
SYYSYSCO CORP5/921.7+3.2%
PFGCPerformance Food Group Co4/91.9251+8.6%

All Wholesale Trade companies →

FAQ

Is FZMD financially healthy?

Fuse Medical, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does FZMD pay a dividend?

No, Fuse Medical, Inc. does not currently pay a dividend.

How profitable is FZMD?

In FY2022, Fuse Medical, Inc. had a net margin of 16.6%.

Source: SEC EDGAR filings · CIK 0000319016 · US · as of 2022-12-31. facts plus Stocktoria's own computed scores — not investment advice.